Publications

  1. Chauhan K, Ebner DK, Tzou K, Ryan K, May J, Kaleem T, Miller D, Stross W, Malouff TD, Landy R, Strong G, Herchko S, Serago C, Trifiletti DM, Miller RC, Buskirk S, Waddle MR. Assessment of bladder filling during prostate cancer radiation therapy with ultrasound and cone-beam CT. Front Oncol. 2023; 13:1200270 Epub 2023 July 27
    View PubMed
  2. Bolling JP, Dagan R, Rutenberg M, Mamalui-Hunter M, Buskirk SJ, Heckman MG, Hochwald AP, Slopsema R. Treatment of Uveal Melanoma With Radioactive Iodine 125 Implant Compared With Proton Beam Radiotherapy. Mayo Clin Proc Innov Qual Outcomes. 2022 Feb; 6 (1):27-36 Epub 2021 Dec 22
    View PubMed
  3. Bush A, Malouff TD, Peterson JL, Tzou KS, Jr BCM, Trifiletti DM, Buskirk SJ, Hoppe BS. Palliative Radiotherapy for Nonagenarians: A 5-Year Retrospective Analysis. Int J Radiat Oncol Biol Phys. 2021 Nov 1; 111 (3S):e485-e486
    View PubMed
  4. Dyrbye LN, Major-Elechi B, Hays JT, Fraser CH, Buskirk SJ, West CP. Physicians' Ratings of their Supervisor's Leadership Behaviors and Their Subsequent Burnout and Satisfaction: A Longitudinal Study. Mayo Clin Proc. 2021 Oct; 96 (10):2598-2605 Epub 2021 Sept 15
    View PubMed
  5. Dyrbye LN, Major-Elechi B, Thapa P, Hays JT, Fraser CH, Buskirk SJ, West CP. Characterization of Nonphysician Health Care Workers' Burnout and Subsequent Changes in Work Effort. JAMA Netw Open. 2021 Aug 2; 4 (8):e2121435 Epub 2021 Aug 02
    View PubMed
  6. Malouff TD, TerKonda SP, Knight D, Abu Dabrh AM, Perlman AI, Munipalli B, Dudenkov DV, Heckman MG, White LJ, Wert KM, Pascual JM, Rivera FA, Shoaei MM, Leak MA, Harrell AC, Trifiletti DM, Buskirk SJ. Physician Satisfaction With Telemedicine During the COVID-19 Pandemic: The Mayo Clinic Florida Experience. Mayo Clin Proc Innov Qual Outcomes. 2021 Aug; 5 (4):771-782 Epub 2021 July 01
    View PubMed
  7. Malouff TD, Vallow LA, Seneviratne D, Mahajan A, Foote RL, Hoppe B, Beltran C, Buskirk SJ, Krishnan S, Trifiletti DM. Estimating the Number of Patients Eligible for Carbon Ion Radiotherapy in the United States. Int J Part Ther. 2020 Fall; 7(2):31-41. Epub 2020 Nov 05.
    View PubMed
  8. Malouff TD, Stross WC, Seneviratne DS, Waddle MR, May BC, Buskirk SJ, Tzou KS. Current use of stereotactic body radiation therapy for low and intermediate risk prostate cancer: A National Cancer Database Analysis. Prostate Cancer Prostatic Dis. 2020 Jun; 23 (2):349-355 Epub 2019 Nov 28
    View PubMed
  9. Waddle MR, Stross WC, Vallow LA, Naessens JM, White L, Meier S, Spaulding AC, Buskirk SJ, Trifiletti DM, Keole SR, Ma DJ, Bajaj GK, Laack NN, Miller RC. Impact of patient stage and disease characteristics on the proposed Radiation Oncology Alternative Payment Model (RO-APM) International Journal of Radiation Oncology Biology Physics. 2020 Apr 1; 106(5):905-11. Epub 1900 Jan 01.
  10. Dyrbye LN, Major-Elechi B, Hays JT, Fraser CH, Buskirk SJ, West CP. Relationship Between Organizational Leadership and Health Care Employee Burnout and Satisfaction. Mayo Clin Proc. 2020 Apr; 95 (4):698-708
    View PubMed
  11. Rihal CS, Baker NA, Bunkers BE, Buskirk SJ, Caviness JN, Collins EA, Copa JC, Hayes SN, Hubert SL, Reed DA, Wendorff SR, Fraser CH, Farrugia G, Noseworthy JH. Addressing Sexual Harassment in the #MeToo Era: An Institutional Approach. Mayo Clin Proc. 2020 Apr; 95 (4):749-757
    View PubMed
  12. Waddle MR, Stross WC, Vallow LA, Naessens JM, White L, Meier S, Spaulding AC, Buskirk SJ, Trifiletti DM, Keole SR, Ma DJ, Bajaj GK, Laack NN, Miller RC. Impact of Patient Stage and Disease Characteristics on the proposed Radiation Oncology Alternative Payment Model (RO-APM). Int J Radiat Oncol Biol Phys. 2020 Apr 1; 106 (5):905-911 Epub 2020 Jan 28
    View PubMed
  13. Whitaker TJ, Mayo CS, Ma DJ, Haddock MG, Miller RC, Corbin KS, Neben-Wittich M, Leenstra JL, Laack NN, Fatyga M, Schild SE, Vargas CE, Tzou KS, Hadley AR, Buskirk SJ, Foote RL. Data collection of patient outcomes: one institution's experience. J Radiat Res. 2018 Mar 1; 59 (suppl_1):i19-i24
    View PubMed
  14. Hintenlang LL, Miller DH, Kaleem T, Patel N, May BC, Tzou KS, Vallow LA, Buskirk SJ, Miller RC, Ko SJ, Jaeckle KA, Trifiletti DM, Peterson JL. Treatment of a glioblastoma multiforme dural metastasis with stereotactic radiosurgery: A case report and select review of the literature. J Clin Neurosci. 2018 Feb; 48:118-121 Epub 2017 Nov 26
    View PubMed
  15. Kaleem T, Miller D, Waddle MR, Yanez M, Gianforti B, Buskirk S. Implementation of patient pagers in radiation oncology waiting rooms for patient privacy and satisfaction. BMC Res Notes. 2018 Jan 22; 11 (1):59
    View PubMed
  16. Patel AB, Tzou KS, Single M, Hollant L, Smart B, Gaines K, Sherman C, Peterson JL, Ko SJ, Vallow LA, Miller RC, Buskirk SJ. Radiation therapy prophylaxis for heterotopic ossification in non-hip sites. Journal of Cancer Therapy. 2017.
  17. Patel AJ, Tzou KS, Heckman MG, Thomas CS, Lee RJ, Paryani N, Peterson JL, Miller RC, Ko SJ, Vallow LA, Buskirk SJ. Estimation of PSA Half-Life Following Salvage Radiation Therapy Journal of Cancer Therapy. 2017.
  18. Robinson JL, Tzou KS, Parker AS, Heckman MG, Wu KJ, Hilton TW, Pisansky TM, Schild SE, Peterson JL, Vallow LA, Buskirk SJ. GATA2 expression and biochemical recurrence following salvage radiation therapy for relapsing prostate cancer. Br J Radiol. 2017 Jul; 90 (1075):20170174 Epub 2017 June 16
    View PubMed
  19. Habboush Y, Shannon RP, Niazi SK, Hollant L, Single M, Gaines K, Smart B, Chimato NT, Heckman MG, Buskirk SJ, Vallow LA, Tzou KS, Ko SJ, Peterson JL, Biers HA, Day AB, Nelson KA, Sloan JA, Halyard MY, Miller RC. Patient-reported distress and survival among patients receiving definitive radiation therapy. Adv Radiat Oncol. 2017 Apr-Jun; 2 (2):211-219 Epub 2017 Mar 20
    View PubMed
  20. Whitaker DA Jr, Miller DH, Jagadesh N, Strong GW, Hintenlang L, Schenk WB, Broderick GA, Tzou KS, Buskirk SJ. Small Cell Carcinoma of the Prostate in an Elderly Patient: A Case Report and Review of the Literature. Rare Tumors. 2016 Nov 17; 8 (4):6657 Epub 2016 Dec 20
    View PubMed
  21. Stish BJ, Pisansky TM, Harmsen WS, Davis BJ, Tzou KS, Choo R, Buskirk SJ. Improved Metastasis-Free and Survival Outcomes With Early Salvage Radiotherapy in Men With Detectable Prostate-Specific Antigen After Prostatectomy for Prostate Cancer. J Clin Oncol. 2016 Nov 10; 34 (32):3864-3871
    View PubMed
  22. Lee RJ, Tzou KS, Heckman MG, Hobbs CJ, Rawal B, Diehl NN, Peterson JL, Paryani NN, Ko SJ, Daugherty LC, Vallow LA, Wong W, Schild S, Pisansky TM, Buskirk SJ. Proposed prognostic scoring system evaluating risk factors for biochemical recurrence of prostate cancer after salvage radiation therapy. BJU Int. 2016 Aug; 118 (2):236-42 Epub 2015 Aug 22
    View PubMed
  23. Shanafelt TD, Mungo M, Schmitgen J, Storz KA, Reeves D, Hayes SN, Sloan JA, Swensen SJ, Buskirk SJ. Longitudinal Study Evaluating the Association Between Physician Burnout and Changes in Professional Work Effort. Mayo Clin Proc. 2016 Apr; 91 (4):422-31
    View PubMed
  24. Heckman MG, Robinson JL, Tzou KS, Parker AS, Wu KJ, Hilton TW, Howat WJ, Miller JL, Kreinest PA, Pisansky TM, Schild SE, Peterson JL, Vallow LA, Carroll JS, Buskirk SJ. An Examination of the Association between FOXA1 Staining Level and Biochemical Recurrence following Salvage Radiation Therapy for Recurrent Prostate Cancer. PLoS One. 2016; 11 (3):e0151785 Epub 2016 Mar 17
    View PubMed
  25. Miller DH, Peterson JL, Buskirk SJ, Vallow LA, Ta R, Joseph R, Krishna M, Ko SJ, Tzou KS. Management of Metastatic Apocrine Hidradenocarcinoma with Chemotherapy and Radiation. Rare Tumors. 2015 Sep 7; 7 (3):6082 Epub 2015 Oct 05
    View PubMed
  26. Shanafelt TD, Gorringe G, Menaker R, Storz KA, Reeves D, Buskirk SJ, Sloan JA, Swensen SJ. Impact of organizational leadership on physician burnout and satisfaction. Mayo Clin Proc. 2015 Apr; 90 (4):432-40 Epub 2015 Mar 18
    View PubMed
  27. Paryani NN, Peterson JL, Albold C, Taylor SR, Vallow L, Ko SJ, Buskirk SJ. Resident Understanding of ACGME Core Competencies Journal of Nature and Science. 2015; 1(2):e39.
  28. Peterson JL, Buskirk SJ, Heckman MG, Diehl NN, Bernard JR Jr, Tzou KS, Casale HE, Bellefontaine LP, Serago C, Kim S, Vallow LA, Daugherty LC, Ko SJ. Image-guided intensity-modulated radiotherapy for prostate cancer: Dose constraints for the anterior rectal wall to minimize rectal toxicity. Med Dosim. 2014 Spring; 39(1):12-7. Epub 2013 Oct 04.
    View PubMed
  29. Patel SH, Munson ND, Grant DG, Buskirk SJ, Hinni ML, Perry WC, Foote RL, McNeil RB, Halyard MY. Relapse patterns after transoral laser microsurgery and postoperative irradiation for squamous cell carcinomas of the tonsil and tongue base. Ann Otol Rhinol Laryngol. 2014 Jan; 123(1):32-9.
    View PubMed
  30. Peterson JL, Vallow LA, Johnson DW, Heckman MG, Diehl NN, Smith AA, Tzou KS, Paz-Fumagalli R, Kim S, Ko SJ, Daugherty LC, Kim GP, Brown N, Mori KW, Buskirk SJ. Complications after 90Y microsphere radioembolization for unresectable hepatic tumors: An evaluation of 112 patients. Brachytherapy. 2013 Nov-Dec; 12 (6):573-9 Epub 2013 Aug 14
    View PubMed
  31. Heckman MG, Tzou KS, Parker AS, Pisansky TM, Schild SE, Hilton TW, Patel VN, Pelaez L, Khor LY, Peterson JL, Daugherty LC, Vallow LA, Pollack A, Buskirk SJ. Lack of Association between COX-2 Staining Level and Biochemical Recurrence Following Salvage Radiation Therapy for Recurrent Prostate Cancer. J Radiat Oncol. 2013 Sep 1; 2 (3):309-314
    View PubMed
  32. Peterson JL, Buskirk SJ, Heckman MG, Parker AS, Diehl NN, Tzou KS, Paryani NN, Ko SJ, Daugherty LC, Vallow LA, Pisansky TM. Evaluation of Serum Calcium as a Predictor of Biochemical Recurrence following Salvage Radiation Therapy for Prostate Cancer. ISRN Oncol. 2013; 2013:239241 Epub 2013 Mar 31
    View PubMed
  33. Tan WW, Heckman MG, Vishnu P, Crook JE, Younkin LH, Covil EG, Ferman TJ, Graff-Radford NR, Younkin SG, Smallridge RC, Wehle MJ, Buskirk SJ. Effect of leuprolide on serum amyloid-beta peptide levels and memory in patients with prostate cancer with biochemical recurrence. Urology. 2013 Jan; 81 (1):150-4
    View PubMed
  34. Heckman MG, Parker AS, Wu KJ, Hilton TW, Ko SJ, Pisansky TM, Schild SE, Khor LY, Hammond EH, Pollack A, Buskirk SJ. Evaluation of MDM2, p16, and p53 staining levels as biomarkers of biochemical recurrence following salvage radiation therapy for recurrent prostate cancer. Prostate. 2012 Dec 1; 72 (16):1757-66 Epub 2012 Apr 18
    View PubMed
  35. Foote RL, Stafford SL, Petersen IA, Pulido JS, Clarke MJ, Schild SE, Garces YI, Olivier KR, Miller RC, Haddock MG, Yan E, Laack NN, Arndt CA, Buskirk SJ, Miller VL, Brent CR, Kruse JJ, Ezzell GA, Herman MG, Gunderson LL, Erlichman C, Diasio RB. The clinical case for proton beam therapy. Radiat Oncol. 2012 Oct 22; 7:174
    View PubMed
  36. Panjala C, Nguyen JH, Al-Hajjaj AN, Rosser BA, Nakhleh RE, Bridges MD, Ko SJ, Buskirk SJ, Kim GP, Harnois DM. Impact of neoadjuvant chemoradiation on the tumor burden before liver transplantation for unresectable cholangiocarcinoma. Liver Transpl. 2012 May; 18(5):594-601.
    View PubMed
  37. Kowalchik KV, Vallow LA, McDonough M, Thomas CS, Heckman MG, Peterson JL, Adkisson CD, Serago C, Buskirk SJ, McLaughlin SA. The role of preoperative bilateral breast magnetic resonance imaging in patient selection for partial breast irradiation in ductal carcinoma in situ. Int J Surg Oncol. 2012; 2012:206342 Epub 2012 May 13
    View PubMed
  38. Parker AS, Heckman MG, Sheinin Y, Wu KJ, Hilton TW, Diehl NN, Pisansky TM, Schild SE, Kwon ED, Buskirk SJ. Evaluation of B7-H3 expression as a biomarker of biochemical recurrence after salvage radiation therapy for recurrent prostate cancer. Int J Radiat Oncol Biol Phys. 2011 Apr 01; 79(5):1343-9. Epub 2010 Jul 02.
    View PubMed
  39. Tzou K, Tan WW, Buskirk S. Treatment of men with rising prostate-specific antigen levels following radical prostatectomy. Expert Rev Anticancer Ther. 2011 Jan; 11(1):125-36.
    View PubMed
  40. Bernard JR, Vallow LA, DePeri ER, McNeil RB, Feigel DG, Amar S, Buskirk SJ, Perez EA. In newly diagnosed breast cancer, screening MRI of the contralateral breast detects mammographically occult cancer, even in elderly women: the mayo clinic in Florida experience. Breast J. 2010 Mar-Apr; 16(2):118-26. Epub 2010 Jan 29.
    View PubMed
  41. Bernard JR Jr, Buskirk SJ, Heckman MG, Diehl NN, Ko SJ, Macdonald OK, Schild SE, Pisansky TM. Salvage radiotherapy for rising prostate-specific antigen levels after radical prostatectomy for prostate cancer: dose-response analysis. Int J Radiat Oncol Biol Phys. 2010 Mar 1; 76 (3):735-40 Epub 2009 May 21
    View PubMed
  42. Parker AS, Heckman MG, Wu KJ, Crook JE, Hilton TW, Pisansky TM, Bernard JR, Schild SE, Khor LY, Hammond EH, Pollack A, Buskirk SJ. Evaluation of ki-67 staining levels as an independent biomarker of biochemical recurrence after salvage radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2009 Dec 01; 75(5):1364-70. Epub 2009 May 21.
    View PubMed
  43. Peterson JL, Buskirk SJ, Heckman MG, Crook JE, Ko SJ, Wehle MJ, Igel TC, Prussak KA, Pisansky TM. Late toxicity after postprostatectomy salvage radiation therapy. Radiother Oncol. 2009 Nov; 93 (2):203-6 Epub 2009 Sept 18
    View PubMed
  44. Jain AK, Vallow LA, Gale AA, Buskirk SJ. Does three-dimensional external beam partial breast irradiation spare lung tissue compared with standard whole breast irradiation? Int J Radiat Oncol Biol Phys. 2009 Sep 1; 75 (1):82-8 Epub 2009 Feb 21
    View PubMed
  45. Moore LF, Kransdorf MJ, Buskirk SJ, O'Connor MI, Menke DM. Radiation-induced pseudotumor following therapy for soft tissue sarcoma. Skeletal Radiol. 2009 Jun; 38 (6):579-84 Epub 2009 Feb 17
    View PubMed
  46. Gale AA, Jain AK, Vallow LA, Serago CF, Buskirk SJ, Heckman MG. Cardiac dose evaluation for 3-dimensional conformal partial breast irradiation compared with whole breast irradiation. J Appl Clin Med Phys. 2009 Jan 14; 10 (1):3-13
    View PubMed
  47. Peterson JL, Vallow LA, Hines SL, Buskirk SJ. Ductal carcinoma in situ of the breast. Oncology Reviews. 2009; 3(4):237-46.
  48. Wong WW, Buskirk SJ, Schild SE, Prussak KA, Davis BJ. Combined prostate brachytherapy and short-term androgen deprivation therapy as salvage therapy for locally recurrent prostate cancer after external beam irradiation. J Urol. 2006 Nov; 176 (5):2020-4
    View PubMed
  49. Buskirk SJ, Pisansky TM, Schild SE, Macdonald OK, Wehle MJ, Kozelsky TF, Collie AC, Ferrigni RG, Myers RP, Prussak KA, Heckman MG, Crook JE, Parker AS, Igel TC. Salvage radiotherapy for isolated prostate specific antigen increase after radical prostatectomy: evaluation of prognostic factors and creation of a prognostic scoring system. J Urol. 2006 Sep; 176(3):985-90.
    View PubMed
  50. Serago CF, Buskirk SJ, Igel TC, Gale AA, Serago NE, Earle JD. Comparison of daily megavoltage electronic portal imaging or kilovoltage imaging with marker seeds to ultrasound imaging or skin marks for prostate localization and treatment positioning in patients with prostate cancer. Int J Radiat Oncol Biol Phys. 2006 Aug 01; 65: (5)1585-92.
    View PubMed
  51. Buskirk SJ, Kraft KJ, Witt NJ, Scheuer AK, Gianforti BL, DeGuzman ML, Hunter CA, Guida M, Serago CF, Schild SE, Collie AC. Salvage radiotherapy for patients with increasing prostate-specific antigen levels after radical prostatectomy: Evaluation of the role of retrograde urethrography. Journal of Radiotherapy in Practice. 2006; 5(2):117-20.
  52. Buskirk SJ, Pinkstaff DM, Petrou SP, Wehle MJ, Broderick GA, Young PR, Weigand SD, O'Brien PC, Igel TC. Acute urinary retention after transperineal template-guided prostate biopsy. Int J Radiat Oncol Biol Phys. 2004 Aug 1; 59(5):1360-6.
    View PubMed
  53. Maples WJ, Buskirk SJ. Multimodality treatment of upper extremity bone and soft tissue sarcomas. Hand Clin. 2004 May; 20(2):221-5.
    View PubMed
  54. Wehle MJ, Lisson SW, Buskirk SJ, Broderick GA, Young PR, Igel TC. Prediction of genitourinary tract morbidity after brachytherapy for prostate adenocarcinoma. Mayo Clin Proc. 2004 Mar; 79(3):314-7.
    View PubMed
  55. Reed D, Wallner K, Merrick G, Buskirk S, True L. Clinical correlates to PSA spikes and positive repeat biopsies after prostate brachytherapy. Urology. 2003 Oct; 62(4):683-8.
    View PubMed
  56. Serago CF, Chungbin SJ, Buskirk SJ, Ezzell GA, Collie AC, Vora SA. Initial experience with ultrasound localization for positioning prostate cancer patients for external beam radiotherapy. Int J Radiat Oncol Biol Phys. 2002 Aug 1; 53 (5):1130-8
    View PubMed
  57. Buskirk SJ, Pisansky TM, Atkinson EJ, Schild SE, O'Brien PC, Wolfe JT, Zincke H. Lymph node-positive prostate cancer: evaluation of the results of the combination of androgen deprivation therapy and radiation therapy. Mayo Clin Proc. 2001 Jul; 76(7):702-6.
    View PubMed
  58. Woodward TA, Menke DM, Buskirk SJ. Solitary pelvic nodule: diagnosis of metastatic prostate cancer by endoscopic ultrasound-guided, fine-needle aspiration. Am J Gastroenterol. 2000 Sep; 95: (9)2372-3.
    View PubMed
  59. Pisansky TM, Kozelsky TF, Myers RP, Hillman DW, Blute ML, Buskirk SJ, Cheville JC, Ferrigni RG, Schild SE. Radiotherapy for isolated serum prostate specific antigen elevation after prostatectomy for prostate cancer. J Urol. 2000 Mar; 163(3):845-50.
    View PubMed
  60. Serago CF, Buskirk SJ, Karstaedt N, Wehle M, Igel TC, Casale HE. A comparison of prostate iodine-125 seed dose planning using computed tomography and ultrasound imaging. Journal of Brachytherapy International. 2000; 16(2):111-116.
  61. Foote RL, Buskirk SJ, Grado GL, Bonner JA. Has radiotherapy become too expensive to be considered a treatment option for early glottic cancer? Head Neck. 1997 Dec; 19 (8):692-700
    View PubMed
  62. Foo ML, Gunderson LL, Bender CE, Buskirk SJ. External radiation therapy and transcatheter iridium in the treatment of extrahepatic bile duct carcinoma. Int J Radiat Oncol Biol Phys. 1997 Nov 1; 39 (4):929-35
    View PubMed
  63. McGinnis WL, Loprinzi CL, Buskirk SJ, Sloan JA, Drummond RG, Frank AR, Shanahan TG, Kahanic SP, Moore RL, Schild SE, Humphrey SL. Placebo-controlled trial of sucralfate for inhibiting radiation-induced esophagitis. J Clin Oncol. 1997 Mar; 15(3):1239-43.
    View PubMed
  64. Schild SE, Buskirk SJ, Wong WW, Halyard MY, Swanson SK, Novicki DE, Ferrigni RG. The use of radiotherapy for patients with isolated elevation of serum prostate specific antigen following radical prostatectomy. J Urol. 1996 Nov; 156(5):1725-9.
    View PubMed
  65. Buskirk SJ, Schild SE, Durr ED, Robinow JS, Bock FF, Wolfe JT, Tomera KM, Ferrigni RG. Evaluation of serum prostate-specific antigen levels after postoperative radiation therapy for pathologic stage T3, N0 prostate cancer. Mayo Clin Proc. 1996 Mar; 71 (3):242-8
    View PubMed
  66. Foote RL, Grado GL, Buskirk SJ, Olsen KD, Bonner JA, Earle JD, Kasperbauer JL, McCaffrey TV, Suman VJ. Radiation therapy for glottic cancer using 6-MV photons. Cancer. 1996 Jan 15; 77(2):381-6.
    View PubMed
  67. Olsen KD, Caruso M, Foote RL, Stanley RJ, Lewis JE, Buskirk SJ, Frassica DA, DeSanto LW, O'Fallon WM, Hoverman VR. Primary head and neck cancer. Histopathologic predictors of recurrence after neck dissection in patients with lymph node involvement. Arch Otolaryngol Head Neck Surg. 1994 Dec; 120 (12):1370-4
    View PubMed
  68. Foote RL, Olsen KD, Buskirk SJ, Stanley RJ, Suman VJ. Laryngectomy alone for T3 glottic cancer. Head Neck. 1994 Sep-Oct; 16 (5):406-12
    View PubMed
  69. Schild SE, Wong WW, Grado GL, Buskirk SJ, Robinow JS, Frick LM, Ferrigni RG. Radiotherapy for isolated increases in serum prostate-specific antigen levels after radical prostatectomy. Mayo Clin Proc. 1994 Jul; 69 (7):613-9
    View PubMed
  70. Foote RL, Hilgenfeld RU, Kunselman SJ, Schaid DJ, Buskirk SJ, Grado GL, Earle JD. Radiation therapy for squamous cell carcinoma of the tonsil. Mayo Clin Proc. 1994 Jun; 69 (6):525-31
    View PubMed
  71. Foote RL, Schild SE, Thompson WM, Buskirk SJ, Olsen KD, Stanley RJ, Kunselman SJ, Schaid DJ, Grill JP. Tonsil cancer. Patterns of failure after surgery alone and surgery combined with postoperative radiation therapy. Cancer. 1994 May 15; 73 (10):2638-47
    View PubMed
  72. Schild SE, Scheithauer BW, Schomberg PJ, Hook CC, Kelly PJ, Frick L, Robinow JS, Buskirk SJ. Pineal parenchymal tumors. Clinical, pathologic, and therapeutic aspects. Cancer. 1993 Aug 1; 72 (3):870-80
    View PubMed
  73. Foote RL, Olsen KD, Davis DL, Buskirk SJ, Stanley RJ, Kunselman SJ, Schaid DJ, DeSanto LW. Base of tongue carcinoma: patterns of failure and predictors of recurrence after surgery alone. Head Neck. 1993 Jul-Aug; 15 (4):300-7
    View PubMed
  74. Thompson WM, Foote RL, Olsen KD, Schaid DJ, Grado GL, Buskirk SJ, Earle JD. Postoperative irradiation for tonsillar carcinoma. Mayo Clin Proc. 1993 Jul; 68 (7):665-9
    View PubMed
  75. Perniciaro CV, Buskirk SJ. Extramammary Paget's disease treated with radiotherapy. Journal of Dermatological Treatment. 1993; 3:164-165.
  76. Shaw EG, Brindle JS, Creagan ET, Foote RL, Trastek VF, Buskirk SJ. Locally recurrent non-small-cell lung cancer after complete surgical resection. Mayo Clin Proc. 1992 Dec; 67 (12):1129-33
    View PubMed
  77. Foote RL, Olsen KD, Kunselman SJ, Schaid DJ, Buskirk SJ, Grado GL, Earle JD. Early-stage squamous cell carcinoma of the glottic larynx managed with radiation therapy. Mayo Clin Proc. 1992 Jul; 67 (7):629-36
    View PubMed
  78. Schild SE, Foote RL, Buskirk SJ, Robinow JS, Bock FF, Cupps RE, Earle JD. Results of radiotherapy for chemodectomas. Mayo Clin Proc. 1992 Jun; 67 (6):537-40
    View PubMed
  79. Buskirk SJ, Gunderson LL, Schild SE, Bender CE, Williams HJ Jr, McIlrath DC, Williams HJ Jr, Robinow JS, Tremaine WJ, Martin JK Jr, Martin JK Jr. Analysis of failure after curative irradiation of extrahepatic bile duct carcinoma. Ann Surg. 1992 Feb; 215 (2):125-31
    View PubMed
  80. Schild SE, Buskirk SJ, Robinow JS. Prostate cancer: retrograde urethrography to improve treatment planning for radiotherapy. Radiology. 1992; 181:885-887.
  81. Schild SE, Buskirk SJ, Robinow JS, Tomera KM, Ferrigni RG, Frick LM. The results of radiotherapy for isolated elevation of serum PSA levels following radical prostatectomy. Int J Radiat Oncol Biol Phys. 1992; 23 (1):141-5
    View PubMed
  82. Schild SE, Robinow JS, Casale HE, Bellefontaine LP, Buskirk SJ. Radiotherapy treatment planning for prostate cancer in patients with prosthetic hips. Med Dosim. 1992; 17 (2):83-6
    View PubMed
  83. Schild SE, Buskirk SJ, Robinow JS. Prostate cancer: retrograde urethrography to improve treatment planning for radiation therapy. Radiology. 1991 Dec; 181: (3)885-7.
    View PubMed
  84. Schild SE, Buskirk SJ, Frick LM, Cupps RE. Radiotherapy for large symptomatic hemangiomas. Int J Radiat Oncol Biol Phys. 1991 Aug; 21 (3):729-35
    View PubMed
  85. Foote RL, Buskirk SJ, Stanley RJ, Grambsch PM, Olsen KD, DeSanto LW, Earle JD, Weiland LH. Patterns of failure after total laryngectomy for glottic carcinoma. Cancer. 1989 Jul 1; 64 (1):143-9
    View PubMed
  86. Foote RL, Garretson BR, Schomberg PJ, Buskirk SJ, Robertson DM, Earle JD. External beam irradiation for retinoblastoma: patterns of failure and dose-response analysis. Int J Radiat Oncol Biol Phys. 1989 Mar; 16 (3):823-30
    View PubMed
  87. Martenson JA Jr, Buskirk SJ, Ilstrup DM, Banks PM, Evans RG, Colgan JP, Earle JD. Patterns of failure in primary testicular non-Hodgkin's lymphoma. J Clin Oncol. 1988 Feb; 6: (2)297-302.
    View PubMed
  88. Buskirk SJ, Schray MF, Podratz KC, Lee RA, Lee RA, Stanhope CR, Gaffey TA, Weber FC, Earle JD, Naessens JM, Malkasian GD. Ovarian dysgerminoma: a retrospective analysis of results of treatment, sites of treatment failure, and radiosensitivity. Mayo Clin Proc. 1987 Dec; 62 (12):1149-57
    View PubMed
  89. Martenson JA Jr, Gunderson LL, Buskirk SJ, Nagorney DM, Martin JK, May GR, Bender CE, Tremaine WJ. Hepatic duct stricture after radical radiation therapy for biliary cancer: recurrence or fibrosis? Mayo Clin Proc. 1986 Jul; 61(7):530-6.
    View PubMed
  90. Blair TJ, Evans RG, Buskirk SJ, Banks PM, Earle JD. Radiotherapeutic management of primary thyroid lymphoma. Int J Radiat Oncol Biol Phys. 1985 Feb; 11(2):365-70.
    View PubMed
  91. Buskirk SJ, Gunderson LL, Adson MA, Martinez A, May GR, McIlrath DC, Nagorney DM, Edmundson GK, Bender CE, Martin JK Jr. Analysis of failure following curative irradiation of gallbladder and extrahepatic bile duct carcinoma. Int J Radiat Oncol Biol Phys. 1984 Nov; 10(11):2013-23.
    View PubMed
  92. Buskirk SJ, Evans RG, Banks PM, O'Connell MJ, Earle JD. Primary lymphoma of the testis. Int J Radiat Oncol Biol Phys. 1982 Oct; 8(10):1699-703.
    View PubMed
  93. Buskirk SJ, Evans RG, Farrow GM, Earle JD. Primary retroperitoneal seminoma. Cancer. 1982 May 1; 49(9):1934-6.
    View PubMed